Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by Shoeon Jun 07, 2011 11:54pm
421 Views
Post# 18684744

I like this comparison

I like this comparisonThe epizonal Brewery Creek deposit had an overall grade of 1.44 g/t Au and 17.2 Mt of ore, divided between about eight orebodies, prior to mining and extraction of 9 t (285 000 oz) Au from 1996 to 2002. Parts of some individual orebodies had considerably higher average grades of 4 g/t Au. The overall tonnage of Brewery Creek is misleading because it was explored only for its easily recoverable oxide resource. The underlying sulphide orebody remains undefi ned, but is the focus of current exploration efforts. The Donlin Creek deposit, at 323 Mt of 2.7 g/t Au and with a Au-As- Sb-Hg signature similar to that of Brewery Creek, had also been suggested to be an epizonal RIRGS (Ebert et al., 2000; Thompson and Newberry 2000), but recent studies (Ebert et al., 2003; Goldfarb et al., 2004) indicate otherwise.

https://gsc.nrcan.gc.ca/mindep/synth_dep/gold/rirgs/index_e.php#fig3


The Donlin Creek gold deposit, southwestern Alaska, has an indicatedand inferred resource of approximately 25 million ounces ...

Atac has Carlin trend associated with it....So what the heck we got Donlin part duex? -D

Dare to dream
Shoe
Bullboard Posts